Status:
UNKNOWN
Follow-up After TAVR Without Systematic Intensive Care Unit Admission
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Aortic Valve Stenosis
Eligibility:
All Genders
18+ years
Brief Summary
Since the first case described in 2002, TAVI (transcatheter Aortic Valve Implantation) revolutionized the management of severe symptomatic aortic stenosis. Initially reserved for patients with prohibi...
Detailed Description
Since the first case described in 2002, indications of TAVI (transcatheter Aortic Valve Implantation) procedures increased in the treatment of symptomatic severe aortic stenosis. Initially reserved fo...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- age \> 18 yo
- Patients undergoing a TAVI at Montpellier University Hospital since 2017
- With implantation of a COREVALVE or EDWARDS
- Exclusion criteria:
- Minor patient
- Patient unable to give consent for reasons of understanding or language barrier
- Death before unit admission
- Patients referred to a non cardiological unit after the procedure
Exclusion
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04335149
Start Date
January 1 2017
End Date
December 1 2022
Last Update
May 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295